Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2017-04-06 2017-03-17
Drug Identification Number 02320371 02320371
Brand name CARBOPLATIN INJECTION CARBOPLATIN INJECTION
Common or Proper name CARBOPLATIN CARBOPLATIN
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients CARBOPLATIN CARBOPLATIN
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 45 ML VIAL OF 450 MG | FLACON DE 45 ML DE 450 MG 45 ML VIAL OF 450 MG | FLACON DE 45 ML DE 450 MG
ATC code L01XA L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-02-14 2017-02-14
Actual start date 2017-02-14 2017-02-14
Estimated end date 2017-03-20 2017-03-20
Actual end date 2017-03-20
Shortage status Resolved Actual shortage
Company comments
Health Canada comments